A fragment of C-terminal type V collagen
A novel biochemical plasma marker of true type V collagen formation. Circulating biomarkers, originating from defined fragments of the scar tissue itself, may serve as valuable tools for precision medicine.
Ninety-four patients mainly with alcoholic cirrhosis and fourteen liver-healthy controls were included in a retrospective study. Relevant clinical and routine laboratory data and hemodynamics were determined. Plasma Pro-C5 was correlated to HVPG and liver function parameters. Furthermore, Pro-C5 was combined in a linear regression model.
Plasma Pro-C5 correlated to HVPG, indocyanine green clearance, sustained vascular resistance and mean arterial pressure (r = -0.68-0.33, p < 0.0001). A multiple regression analysis including Pro-C5, alanine aminotransferase, bilirubin and model for end-stage liver disease (MELD) improved the correlation to HVPG (r = 0.74, p < 0.0001). Plasma Pro-C5 was positively or negatively correlated to a number of routine liver function markers and MELD score (r = 0.27-0.68; p < 0.05-0.0001). Furthermore, plasma Pro-C5 could clearly separate patients with a HVPG
Plasma Pro-C5 reflects liver hemodynamics, liver function, disease stage and clinically significant portal hypertension (PH). A multimarker model in combination with clinical scores predicted HVPG and separated clinical relevant HVPG thresholds. Plasma Pro-C5 may be suitable for the noninvasive evaluation of PH in patients with cirrhosis.
Therapeutic area
Gastroenterology, Cancer, Hepatic diseases, Rheumatology
Biomarker panels
Hepatic Fibrosis Outcome, Tissue Fibrosis, Fibrosis / Fibroblasts, Tissue Fibrosis
Function
ECM formation
Alternative names
PROC5
Certification
-
Platform
On high-precision platform
Sample type
Serum
Sample volume
20 µl
Healthy reference range
Reach out to learn more
Species (Tested in)
N/A
Search and find publications that we have published.
Please don't hesitate to contact us if you have any questions or other inquiries.